MSWA provides continued funding to Perron Institute for research
The Perron Institute for Neurological and Translational Science is pleased to announce it has received continued funding from MSWA.
The Institute is one of the recipients of the substantial contribution announced today by MSWA CEO Marcus Stafford.
“MSWA is proud to announce that in this financial year 2021/2022, we are committing a record $10 million to neurological research,” he said.
“This record-breaking contribution to research makes MSWA the largest non-government funder of neurological research in Australia.”
Over the last decade, MSWA has invested more than $20 million towards research.
Perron Institute CEO Steve Arnott is delighted to receive further financial support from MSWA, who over the last five years has been a significant contributor to research at the Perron Institute.
“Continued funding from MSWA is incredibly important as it allows the Perron Institute to strategically deliver outcomes in key areas of unmet need,” he said.
“MSWA’s funding means our researchers can continue striving to find novel treatments for people living with neurological conditions.
“Their support is also helping the Perron Institute to expand its work with both new and existing programs and increase its achievements within various research streams.
“Funding has also allowed certain areas of research to progress more rapidly than otherwise would have been possible.”
This financial year, the areas supported are stroke, multiple sclerosis, brain plasticity, genomic medicine, motor neurone disease and Parkinson’s. Many of the projects will involve collating and analysing clinical data and samples, and funds will assist with resourcing and systems to take the programs forward.
Other local organisations benefiting from this funding round include Curtin University, Edith Cowan University and Telethon Kids Institute, national body MS Research Australia, and the International Progressive MS Alliance.